Secretary for Health and Vice Minister of GACC witness signing of MOU between Hong Kong and Shenzhen on entry-exit health inspection and quarantine (with photos)
******************************************************************************************
Professor Lo said, "I would like to express my gratitude to the GACC for its staunch support to the Hong Kong Special Administrative Region on the entry-exit health inspection and quarantine. Since the signing of the Co-operation Arrangement for Entry-exit Health Inspection and Quarantine between the GACC and the Health Bureau of the Hong Kong Special Administrative Region Government (Co-operation Arrangement) between the Health Bureau (HHB) and the GACC in November last year, the two sides have strengthened the joint efforts in disease prevention and control as well as communication in terms of entry-exit health inspection and quarantine, and the collaboration mechanisms have also been operating smoothly. To better implement the Co-operation Arrangement, the Department of Health (DH) and the Shenzhen Customs District signed the MOU today to further deepen the co-operation between Hong Kong and Shenzhen, safeguard the wellbeing and safety of residents and travellers of the two places, and facilitate customs clearance between Shenzhen and Hong Kong."
At the meeting, Professor Lo and Mr Wang exchanged views on issues of mutual concern, including facilitation measures for cross-boundary flow of special articles, such as human tissues, biological products, and blood and blood-related products, for scientific research purposes as stated in the "Customs' Certain Measures on Supporting Comprehensive Deepening Reform and Opening Up of Shenzhen Park of Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone" recently published by the GACC.
Professor Lo emphasised, "Promoting convenient and highly efficient cross-boundary flow of innovation elements is crucial for supporting the establishment of the GBA Clinical Trial Collaboration Platform by the Greater Bay Area International Clinical Trial Institute in the Hong Kong Park of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone and the Greater Bay Area International Clinical Trials Center in the Shenzhen Park together to extend the research and development network and expedite clinical trials. The HHB will work closely with the GACC and Shenzhen Customs District to take forward timely implementation of relevant cross-boundary facilitation policies."
Today's meeting was another occasion where Professor Lo met with leaders of the GACC after his last visit to the GACC in Beijing in September. The Controller of the Centre for Health Protection of the DH, Dr Edwin Tsui, and the Director (Quality and Safety) of the Hospital Authority, Dr Michael Wong, also attended the meeting today.
Ends/Friday, November 29, 2024
Issued at HKT 10:50
Issued at HKT 10:50
NNNN